SRZN vs. NKGN, INKT, TARA, INAB, CRTX, ESLA, ACHL, SABS, PLUR, and DYAI
Should you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include NKGen Biotech (NKGN), MiNK Therapeutics (INKT), Protara Therapeutics (TARA), IN8bio (INAB), Cortexyme (CRTX), Estrella Immunopharma (ESLA), Achilles Therapeutics (ACHL), SAB Biotherapeutics (SABS), Pluri (PLUR), and Dyadic International (DYAI). These companies are all part of the "medical" sector.
NKGen Biotech (NYSE:NKGN) and Surrozen (NASDAQ:SRZN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.
In the previous week, Surrozen had 1 more articles in the media than NKGen Biotech. MarketBeat recorded 2 mentions for Surrozen and 1 mentions for NKGen Biotech. Surrozen's average media sentiment score of 0.67 beat NKGen Biotech's score of 0.00 indicating that NKGen Biotech is being referred to more favorably in the media.
76.2% of NKGen Biotech shares are held by institutional investors. Comparatively, 66.6% of Surrozen shares are held by institutional investors. 20.0% of NKGen Biotech shares are held by insiders. Comparatively, 43.5% of Surrozen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Surrozen has higher revenue and earnings than NKGen Biotech.
NKGen Biotech has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, Surrozen has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500.
Surrozen received 3 more outperform votes than NKGen Biotech when rated by MarketBeat users.
Surrozen's return on equity of 0.00% beat NKGen Biotech's return on equity.
Summary
Surrozen beats NKGen Biotech on 7 of the 11 factors compared between the two stocks.
Get Surrozen News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SRZN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Surrozen Competitors List
Related Companies and Tools
